Kennebec Savings Bank’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-356
Closed -$9.89K – 250
2025
Q3
$9.89K Buy
+356
New +$9K 0.01% 215

Other funds holding ARKG

Kennebec Savings Bank's ARKG Position: Q4 2025 in Review

Kennebec Savings Bank sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 356 shares — an estimated $9.89K sold.

Kennebec Savings Bank first reported a position in ARKG in Q3 2025 and held it in 1 quarter. The position peaked at $9.89K in Q3 2025. 241 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Kennebec Savings Bank reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Kennebec Savings Bank sold 356 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $9.89K.
  • Kennebec Savings Bank first reported a position in ARK Genomic Revolution ETF in Q3 2025 and held it in 1 quarter.
  • Kennebec Savings Bank's ARK Genomic Revolution ETF position peaked at $9.89K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Kennebec Savings Bank's 13F filing for Q4 2025, filed 22 Jan 2026.